Karman's 26% Drop Fails to Alleviate Overvaluation and Cash Flow Woes

What happened

Karman Holdings' stock price dropped 26%, which a Seeking Alpha article frames as a potential opportunity but not yet a buy. The company reported robust revenue growth, with Q4 sales up 47% and full-year up 37%, driven by acquisitions and strong backlog. However, 2026 guidance implies margin contraction and slower EBITDA growth due to capacity expansion and inorganic growth costs. The DeepValue master report highlights severe overvaluation, with the stock trading at ~435x TTM EPS and ~94x EV/EBITDA, coupled with high leverage and negative operating cash flow. This price decline does not address the fundamental financial risks, as the equity remains priced for perfection without corresponding cash generation.

Implication

Investors should avoid Karman as the high valuation multiples imply unrealistic growth expectations, while actual metrics show thin GAAP profitability and negative cash flow. The reliance on debt-funded acquisitions strains the balance sheet, reducing resilience to budget shifts or execution missteps. Any hiccup in integration or defense funding could lead to substantial downside from current levels. Therefore, a wait-and-see approach is prudent until there is clear evidence of sustained positive cash flow and deleveraging. Focus on monitoring backlog trends and quarterly cash conversion before reconsidering the name.

Thesis delta

The Seeking Alpha article's cautious optimism post-drop does not alter the DeepValue report's strong sell thesis, which is rooted in persistent overvaluation and financial weaknesses. No material shift has occurred; the opportunity is superficial, and core concerns around cash flow, leverage, and valuation remain unchanged. Investors should maintain skepticism and prioritize financial health over growth narratives.